• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亮氨酸拉链核酶在 C2C12 肌管中改善葡萄糖利用,并改善饮食诱导肥胖小鼠的代谢物谱,有益于代谢紊乱。

Lunasin ameliorates glucose utilization in C2C12 myotubes and metabolites profile in diet-induced obese mice benefiting metabolic disorders.

机构信息

Department of Biochemical Science &Technology, National Taiwan University, Taipei, Taiwan.

School of Life Science, Undergraduate and Graduate Programs of Nutrition Science, National Taiwan Normal University, Taipei, Taiwan.

出版信息

Life Sci. 2023 Nov 15;333:122180. doi: 10.1016/j.lfs.2023.122180. Epub 2023 Oct 15.

DOI:10.1016/j.lfs.2023.122180
PMID:37848083
Abstract

AIMS

Obesity is the main cause of low-grade inflammation and oxidation, resulting in insulin resistance. This study aimed to investigate the effects of a seed peptide lunasin on glucose utilization in C2C12 myotubes and the metabolite profiles in obese mice.

MAIN METHODS

C2C12 myotubes were challenged by palmitic acid (PA) to mimic the obese microenvironment and inflammation, cell vitality, and glucose utilization were determined. C57BL6/j mice were divided into low-fat diet (LF), high-fat diet (HF), and HF with intraperitoneally injected lunasin (HFL) groups. Glucose intolerance and metabolite profiles of the tissues were analyzed.

KEY FINDINGS

In vitro, C2C12 myotubes treated with lunasin showed decreased proinflammatory cytokines and increased cell vitality under palmitic acid conditions. Lunasin improved glucose uptake and glucose transporter 4 expression by activating insulin receptor substrate-1 and AKT phosphorylation. Next-generation sequencing revealed that lunasin regulates genes expression by promoting insulin secretion and decreasing oxidative stress. In vivo, HF mice showed increased tricarboxylic acid cycle and uric acid metabolites but decreased bile acids metabolites and specific amino acids. Lunasin intervention improved glucose intolerance and modulated metabolites associated with increased insulin sensitivity and decreased metabolic disorders.

SIGNIFICANCE

This study is the first to reveal that lunasin is a promising regulator of anti-inflammation, anti-oxidation, and glucose utilization in myotubes and ameliorating glucose uptake and metabolite profiles in obese mice, contributing to glucose homeostasis and benefiting metabolic disorders.

摘要

目的

肥胖是低度炎症和氧化的主要原因,导致胰岛素抵抗。本研究旨在探讨种子肽 lunasin 对 C2C12 肌管葡萄糖利用的影响及其在肥胖小鼠中的代谢物谱。

方法

用棕榈酸(PA)刺激 C2C12 肌管模拟肥胖微环境,测定细胞活力和葡萄糖利用情况。将 C57BL6/j 小鼠分为低脂饮食(LF)、高脂饮食(HF)和腹腔注射 lunasin 的高脂饮食(HFL)组。分析葡萄糖耐量和组织代谢物谱。

主要发现

在体外,lunasin 处理的 C2C12 肌管在棕榈酸条件下显示出减少的促炎细胞因子和增加的细胞活力。 lunasin 通过激活胰岛素受体底物-1 和 AKT 磷酸化来提高葡萄糖摄取和葡萄糖转运蛋白 4 的表达。下一代测序显示 lunasin 通过促进胰岛素分泌和减少氧化应激来调节基因表达。在体内,HF 小鼠表现出三羧酸循环和尿酸代谢物增加,但胆汁酸代谢物和特定氨基酸减少。 lunasin 干预改善了葡萄糖耐量,并调节了与增加胰岛素敏感性和减少代谢紊乱相关的代谢物。

意义

本研究首次揭示 lunasin 是肌管抗炎、抗氧化和葡萄糖利用的有前途的调节剂,并改善肥胖小鼠的葡萄糖摄取和代谢物谱,有助于葡萄糖稳态并有益于代谢紊乱。

相似文献

1
Lunasin ameliorates glucose utilization in C2C12 myotubes and metabolites profile in diet-induced obese mice benefiting metabolic disorders.亮氨酸拉链核酶在 C2C12 肌管中改善葡萄糖利用,并改善饮食诱导肥胖小鼠的代谢物谱,有益于代谢紊乱。
Life Sci. 2023 Nov 15;333:122180. doi: 10.1016/j.lfs.2023.122180. Epub 2023 Oct 15.
2
Seed peptide lunasin ameliorates obesity-induced inflammation and regulates immune responses in C57BL/6J mice fed high-fat diet.种子肽 lunasin 可改善高脂肪饮食喂养的 C57BL/6J 小鼠肥胖引起的炎症和调节免疫反应。
Food Chem Toxicol. 2021 Jan;147:111908. doi: 10.1016/j.fct.2020.111908. Epub 2020 Dec 5.
3
Pigment epithelium-derived factor inhibits adipogenesis in 3T3-L1 adipocytes and protects against high-fat diet-induced obesity and metabolic disorders in mice.色素上皮衍生因子抑制 3T3-L1 脂肪细胞的脂肪生成,并防止小鼠高脂肪饮食诱导的肥胖和代谢紊乱。
Transl Res. 2019 Aug;210:26-42. doi: 10.1016/j.trsl.2019.04.006. Epub 2019 May 3.
4
GDF11 does not improve the palmitate induced insulin resistance in C2C12.生长分化因子11不能改善棕榈酸诱导的C2C12细胞胰岛素抵抗。
Eur Rev Med Pharmacol Sci. 2017 Apr;21(8):1795-1802.
5
TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.TGR5 激动剂改善糖尿病小鼠骨骼肌胰岛素抵抗,改善葡萄糖稳态。
Metabolism. 2019 Oct;99:45-56. doi: 10.1016/j.metabol.2019.07.003. Epub 2019 Jul 8.
6
Loss of CCR5 results in glucose intolerance in diet-induced obese mice.CCR5 缺失导致饮食诱导肥胖小鼠出现葡萄糖不耐受。
Am J Physiol Endocrinol Metab. 2013 Oct 1;305(7):E897-906. doi: 10.1152/ajpendo.00177.2013. Epub 2013 Aug 13.
7
Exercise Counterbalances Rho/ROCK2 Signaling Impairment in the Skeletal Muscle and Ameliorates Insulin Sensitivity in Obese Mice.运动可抵消骨骼肌中 Rho/ROCK2 信号传导的损害,并改善肥胖小鼠的胰岛素敏感性。
Front Immunol. 2021 Jun 21;12:702025. doi: 10.3389/fimmu.2021.702025. eCollection 2021.
8
Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle.辛伐他汀在 C2C12 肌管和小鼠骨骼肌中引起胰岛素抵抗的机制。
Biochem Pharmacol. 2019 Jun;164:23-33. doi: 10.1016/j.bcp.2019.02.025. Epub 2019 Feb 20.
9
High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice.高细胞外 ATP 水平通过连接蛋白 1 通道释放,介导饮食诱导肥胖小鼠骨骼肌纤维的炎症和胰岛素抵抗。
Diabetologia. 2021 Jun;64(6):1389-1401. doi: 10.1007/s00125-021-05418-2. Epub 2021 Mar 12.
10
Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation.过氧化物酶体增殖物激活受体γ共激活因子-1在肥胖症中的表达降低:饱和脂肪酸和p38丝裂原活化蛋白激酶激活的潜在致病作用。
J Biol Chem. 2007 May 25;282(21):15439-50. doi: 10.1074/jbc.M611214200. Epub 2007 Apr 6.

引用本文的文献

1
The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease-The Transition from an Adipocentric to Liver-Centric Approach.肝胰岛素抵抗与代谢功能障碍相关脂肪性肝病之间的相互联系——从以脂肪为中心到以肝脏为中心的转变
Curr Issues Mol Biol. 2023 Nov 14;45(11):9084-9102. doi: 10.3390/cimb45110570.